CHICAGO, IL—An investigational agent given by subcutaneous injection can drastically reduce levels of lipoprotein(a), with sustained effects seen out to about 1.5 years, according to data from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results